Skip to main content
. 2021 Oct 7;9:715883. doi: 10.3389/fcell.2021.715883

FIGURE 1.

FIGURE 1

The expression of HK2 in esophageal carcinoma (ESCA) and pan-carcinoma. (A) Oncomine analysis showed the expression level of HK2 mRNA in different tumor types. (B) The TIMER ESCA cohort shows that HK2 mRNA expression levels in different tumor types. (C) Differential expression of HK2 in ESCA and normal tissues was analyzed by TCGA ESCA cohort (D) Difference expression of HK2 in ESCA and normal tissues was analyzed by GSE38129 cohort. (E) Difference expression of HK2 between ESCA and matched normal tissues in GSE23400 cohort. (F) Difference expression of HK2 in different ESCA cell lines and human normal epithelial cell lines. Immunohistochemical staining showed the expression of HK2 in ESCA samples (G) and paracarcinoma samples (H). (I) The mean HK2 IHC score in ESCA tissue (2.32 ± 0.621) was significantly higher than that of matched peritumoral tissue (0.84 ± 0.618). P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; *⁣*⁣**P < 0.0001.